Second-largest private hospital chain in North India, running 14 NABH-accredited multi-specialty hospitals under the Park brand.
Second-largest private hospital chain in North India, running 14 NABH-accredited multi-specialty hospitals under the Park brand.
Earns from patients' hospital stays, procedures, tests and pharmacy sales, with payment coming from cash, private insurance and government health-insurance schemes, so the mix of payers and the number of occupied beds decide returns. New hospitals add capacity but take time to fill.
Moat: narrow (brand, installed base). Largest hospital network in Haryana with an entrenched NABH-accredited multi-specialty footprint.
Headquarters: Gurugram, India · Founded: 2005 · Employees: 6,423
Size Park Medi World (PARKHOSPS.NS) is an India Health Care company (Hospital/Nursing Management) with a market value of $1.10B, the 572nd largest of 1,066 India companies the cockpit tracks. Shares closed at ₹238.04 on 18 Nov 2026.
Performance Over six months the shares fell 3.8%, against -2.2% for the median peer and +3.8% for the India market (cap-weighted) — 10th lowest of 20 in its peer set.
Growth Revenue grew 20.5% over the last twelve months (peer median +11.9%); the operating margin is 20.6% (peer median 10.0%).
Valuation It trades at 30.6× forward earnings against a peer median of 27.1× (8th most expensive of 16).
Price implies For today's price to make sense, revenue must grow about 22% a year for seven years (Req g). Recent delivered growth is +10%, so the hurdle is +12 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 0.8 points above its cost of capital (9.8% WACC).
Next results Next results expected around 3 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ₹18.6B | ₹16.8B | ₹13.9B | ₹12.3B | ₹12.5B |
| Revenue growth | — | +21% | +13% | -2% | — |
| Gross profit | ₹10.7B | ₹9.55B | ₹7.39B | ₹6.66B | ₹7.69B |
| EBITDA | ₹4.55B | ₹4.53B | ₹3.83B | ₹3.18B | ₹3.96B |
| Net income | ₹2.56B | ₹2.58B | ₹2.02B | ₹1.53B | ₹2.20B |
| Free cash flow | n/a | ₹1.88B | ₹468M | ₹2.47B | ₹631M |
| Capital expenditure | n/a | ₹1.20B | ₹1.45B | ₹715M | ₹984M |
| Total debt | ₹5.52B | ₹3.64B | ₹6.82B | ₹6.87B | ₹5.76B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Park Medi World PARKHOSPS.NS | $1.10B | -4% | +21% | 21% | 30.6× | 22.1% |
| Yatharth Hospital and Trauma Care Services YATHARTH.NS | $1.13B | +31% | +50% | 16% | 49.4× | n/a |
| Max Healthcare Institute MAXHEALTH.NS | $10.6B | -4% | +15% | 21% | 55.2× | 45.3% |
| Fortis Healthcare FORTIS.NS | $6.40B | -17% | +18% | 17% | 48.5× | 42.5% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | PARKHOSPS.NS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +4.5% | +1.6% | 8th highest of 20 |
| 6-month return | -3.8% | -2.2% | 10th lowest of 20 |
| Distance from 52-week high | -21.9% | -18.4% | 10th lowest of 21 |
| Revenue growth (TTM) | +20.5% | +11.9% | 5th highest of 21 |
| Operating margin | 20.6% | 10.0% | 3rd highest of 21 |
| Forward P/E | 30.6× | 27.1× | 8th most expensive of 16 |
| Growth the price implies (Req g, 7 yrs) | 22.1% | 11.8% | 3rd most demanding of 15 |
| Growth delivered (Del g) | +10.2% | +10.3% | 7th lowest of 15 |
| Hurdle (Req g minus delivered) | +11.9 pp | -0.3 pp | 2nd most demanding of 15 |
| ROIC minus cost of capital | +0.8 pp | -2.2 pp | 7th highest of 21 |
| EV / EBITDA | 23.5× | 14.6× | 5th most expensive of 16 |
| Net debt / EBITDA | 0.6× | 2.6× | 5th least indebted of 17 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Park Medi World PARKHOSPS.NS | India | $1.10B | -4% | +21% | 21% | 30.6× | 22.1% | +10.2% |
| Yatharth Hospital and Trauma Care Services YATHARTH.NS | India | $1.13B | +31% | +50% | 16% | 49.4× | n/a | n/a |
| Rhon-klinikum RHK.DE | Germany | $1.06B | +15% | +4% | -51% | 22.5× | n/a | n/a |
| Jupiter Life Line Hospitals JLHL.NS | India | $1.01B | +9% | +17% | 16% | 48.8× | n/a | n/a |
| Clinica Baviera CBAV.MC | Spain | $1.01B | +2% | +11% | 20% | 20.1× | 2.3% | +19.7% |
| CVS CVSG.L | United Kingdom | $1.22B | +17% | +6% | 11% | 14.6× | 14.2% | +6.9% |
| Raffles Medical BSL.SI | Singapore | $1.23B | -13% | -3% | 11% | 27.1× | -2.7% | +6.1% |
| Ramsay Generale de Sante GDS.PA | France | $969M | -25% | +3% | 4% | n/a | 6.1% | +6.0% |
| Paras Healthcare PARASHLTH.NS | India | $962M | n/a | +24% | 11% | n/a | n/a | n/a |
| HealthCare Global Enterprises HCG.NS | India | $955M | -7% | +13% | 8% | 88.8× | n/a | n/a |
| Spire Healthcare SPI.L | United Kingdom | $1.31B | +11% | +2% | 8% | 25.1× | 10.0% | +11.4% |
| Thomson Medical A50.SI | Singapore | $923M | -18% | +6% | 10% | n/a | 21.2% | +11.8% |
| Sanbo Hospital Management 301293.SZ | China | $1.35B | -29% | +17% | 6% | 135.5× | n/a | n/a |
| Rainbow Childrens Medicare RAINBOW.NS | India | $1.37B | -7% | +23% | 22% | 40.4× | 30.7% | +21.2% |
| Aevis Victoria AEVS.SW | Switzerland | $1.43B | +8% | +15% | -6% | 106.8× | 26.5% | +10.2% |
| Xi'an International Medical Investment 000516.SZ | China | $1.46B | -2% | -1% | -2% | n/a | 12.7% | +20.6% |
| Sienna Senior Living SIA.TO | Canada | $1.58B | -8% | +15% | 10% | 40.9× | 18.9% | +8.6% |
| Kovai Medical Center & Hospital KOVAI.NS | India | $759M | +22% | +17% | 21% | n/a | 17.4% | +18.1% |
| Huaxia Eye Hospital 301267.SZ | China | $1.78B | -18% | +2% | 15% | 23.5× | 2.1% | +10.4% |
| Extendicare EXE.TO | Canada | $1.91B | -16% | +36% | 9% | 19.3× | 10.8% | +8.5% |
| Ardent Health ARDT | United States | $2.03B | +52% | +2% | 5% | 11.9× | -1.7% | +8.7% |